1）He X, Zeng B, Wang Y, Pang Y, Zhang M, Hu T, Liang Y, Kang M, Tang S.
Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study. Frontiers in Immunology. 2023 Oct 17;14:1257360. doi:10.3389/fimmu.2023.1257360. eCollection 2023.
2）Kang M, Yi Y, Li Y, Sun L, Deng A, Hu T, Zhang J, Liu J, Cheng M, Xie S, Luo M, Jiang J, Jiang Y, Tang S, He J. Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China: A Cohort Study. Annals of Internal Medicine. 2022 Feb 1:M21-3509. doi: 10.7326/M21-3509
3）Liang Y, Lin H, Zou L, Deng X, Tang S. Rapid detection and tracking of Omicron variant of SARS-CoV-2 using CRISPR-Cas12a-based assay. Biosensors & Bioelectronics. 2022 Feb 17; 205:114098
4）Cheng Z, Yan H, Li Q, Ablan SD, Kleinpeter A, Freed EO, Wu H, Dzakah EE, Zhao J, Han Z, Wang H, Tang S. Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China. Microbiology Spectrum. 2022 Aug 31;10(4):e0014622
5）Chen S, Wu J, Yang X, Sun Q, Liu S, Rashid F, Dzakah EE, Wang H, Wang J, Gong P, Tang S. RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature. Microbiology Spectrum. 2022 Aug 18:e0272922. doi: 10.1128/spectrum.02729-22
6）Dzakah EE, Zhao J, Wang L, Rashid F, Xu R, Yang L, Wan Z, Huang L, Wang H, Chen S, Ke W, Kyei F, Deng K, Tang S. Chlamydia trachomatis Stimulation Enhances HIV-1 Susceptibility through the Modulation of a Member of the Macrophage Inflammatory Proteins. Journal of Investigative Dermatology. 2021 Oct 15:S0022-202X(21)02318-6
7）Yan H, Wu H, Xia Y, Huang L, Liang Y, Li Q, Chen L, Han Z, Tang S. Acquisition and transmission of HIV-1 among migrants and Chinese in Guangzhou, China from 2008 to 2012: Phylogenetic analysis of surveillance data. Infection Genetics Evolution. 2021 Aug;92:104870
8）Wan Z, Liu J, Hu F, Shui J, Li L, Wang H, Tang X, Hu C, Liang Y, Zhou Y, Cai W, Tang S. Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication. Emerging Microbes & Infection. 2020; 9(1):485-495
9）Wang H, Wan Z, Xu R, Guan Y, Zhu N, Li J, Xie Z, Lu A, Zhang F, Fu Y, Tang S. A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection. Clinical Infectious Diseases. 2018; 66(1):29-35
10）Wang H, Wan Z, Sun Q, Wu Y, Li X, An X, Deng S, Zhu N, Ren X, Tong Y, Tang S. Second Human Pegivirus in Hepatitis C Virus-Infected and Hepatitis C Virus/HIV-1-Co-infected Persons Who Inject Drugs, China. Emerging Infectious Diseases 2018; 24(5):908-911
